Cannabix Technologies Inc. is a developer of marijuana and alcohol breathalyzer technologies for law enforcement, workplaces, and laboratories. The company, founded in 2011, is focused on developing tools for the detection of THC in breath. It is working on delta-9 THC and alcohol screening devices, with delta-9 THC being the primary psychoactive ingredient in cannabis. This technology enables employers and law enforcement to identify recent marijuana use. Additionally, Cannabix is known for its "Breath Logix" alcohol detection devices, which provide autonomous breath testing for employers and other settings, ultimately saving time and money for customers. The company received a significant $4.60M Post-IPO Equity investment on 17 November 2017. Although the headquarters location is not specified, Cannabix Technologies Inc. operates within the Information Technology industry.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Post-IPO Equity | $4.60M | - | 17 Nov 2017 | |
Post-IPO Equity | $2.08M | - | 14 Mar 2016 |
No recent news or press coverage available for Cannabix Technologies Inc.